Inspections, Compliance, Enforcement, and Criminal Investigations

Preface

Public Comment

Comments and suggestions may be submitted at any time to the Division of Compliance Policy (HFC-230), Office of Enforcement, Office of Regulatory Affairs (ORA), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857. Please refer to the exact title of this document when submitting comments or suggestions. For questions regarding the use or interpretation of this chart contact Chris Anders at (240) 632-6853, or e-mail Christopher.Anders@fda.hhs.gov.

Additional Copies

Additional copies are available from the Internet at: http://www.fda.gov/ora/compliance_ref/bimo/fda_epa_oecd.html. Submit written requests for single copies of the guidance entitled "Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLP" to the Division of Compliance Policy (HFC-230), Office of Enforcement, Office of Regulatory Affairs (ORA), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857. Send one self-addressed adhesive label to assist the office in processing your requests.

Page Last Updated: 04/15/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.